PCSA

Conviction 41HealthcareScan · Mon, Aug 10, 2026

Inverted hammer

PCSA$2.65+3.11%

ResistanceSupportVol 14Insider buy

Vol MA14 910.07K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Processa Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.processapharmaceuticals.com ↗

Price2.65

Change+3.11%

Gap+2.33%

Rel volume0.36×

Avg volume656.82K

Avg $ vol1.37M

SMA 202.38

SMA 502.26

SMA 2002.20

Price vs 50+17.28%

Price vs 200+20.43%

MA stackbullish

50/200 cross—

Supertrendup · 1.97

RSI (14)58

MACD hist0.02

MACD crossbull · 0d

Stoch %K / %D65 / 54

ADX (14)18

+DI / −DI29 / 15

RSI divergence—

MACD divergence—

ATR %+11.10%

ADR %11.22%

52w high6.68

52w low0.1202

From 52w high-60.33%

Above 52w low+2104.66%

New 52w highNo

SqueezeOff

Bollinger width45.44%

%B0.75

Donchian pos64.89%

Donchian high3.11

Donchian low1.80

AVWAP (52w high)4.82

vs AVWAP high-44.99%

AVWAP (52w low)4.29

vs AVWAP low-38.18%

OBV trendDown

Chaikin MF (20)-0.11

Today vs 20d0.36×

Avg vol (14d)910.07K

Avg vol (20d)656.82K

Avg $ vol (20d)1.37M

Market cap—

RS 3m (vs SPY)-16.15%

RS 6m (vs SPY)+4.32%

RS line new highNo

Trend template5/8

Technical rank85.7

1 week+24.41%

1 month+22.69%

3 months-2.93%

6 months+11.34%

1 year+1046.69%

YTD-9.56%

P/E-0.53

P/B2.83

P/S—

P/FCF-0.63

EPS-10.36

Div yield0.60%

ROE-533.82%

ROA-300.02%

Debt/Eq0.10

Current0.98

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-14.46%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value5.74M

Revenue0

Net income-3.38M

Gross profit5K

Free cash flow-11.39M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees12

ListedMon, Oct 7, 2013

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction41 / 100

Pattern quality—

Tech rank85.7 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmInverted hammer

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PCSA

All disclosures →

No recent disclosed trades by Congress in PCSA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PCSA · 9 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Guy Wendy Chief Administrative Officer · Restricted Stock Units · 2026-07-26	Grant	9.45K	—	2026-07-26	2026-07-28
Lin Patrick Chief Business - Strategy Off · Restricted Stock Units · 2026-07-26	Grant	8.45K	—	2026-07-26	2026-07-28
Neal James R Director · Restricted Stock Units · 2026-07-26	Grant	62.22K	—	2026-07-26	2026-07-28
Baluch Khoso Director · Restricted Stock Units · 2026-07-26	Grant	33.5K	—	2026-07-26	2026-07-28
Ng George K Chief Executive Officer · Restricted Stock Units · 2026-07-26	Grant	9.38K	—	2026-07-26	2026-07-28
Pannu Geraldine Director · Restricted Stock Units · 2026-07-26	Grant	33.5K	—	2026-07-26	2026-07-28
SKIBSTED RUSSELL Chief Financial Officer · Restricted Stock Units · 2026-07-26	Grant	11.88K	—	2026-07-26	2026-07-28
Yorke Justin W Director · Restricted Stock Units · 2026-07-26	Grant	33.5K	—	2026-07-26	2026-07-28
Neal James R Director · Restricted Stock · 2026-06-26	Exercise	203	—	2026-06-26	2026-06-30
Baluch Khoso Director · Common Stock · 2026-06-26	Exercise	203	—	2026-06-26	2026-06-30

SEC filings

EDGAR filings in PCSA · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.